Activation of Phosphodiesterase 3A: New Hope for Cardioprotection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activation of Phosphodiesterase 3A: New Hope for Cardioprotection

Published:2022-12-06 Issue:23 Volume:146 Page:1779-1782
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Chiong Mario¹^ORCID,Houslay Miles D.²^ORCID,Lavandero Sergio¹³^ORCID

Affiliation:

1. From Advanced Center for Chronic Diseases (ACCDiS), Faculty Chemical & Pharmaceutical Sciences & Faculty of Medicine, University of Chile, Santiago (M.C., S.L.).

2. Mironid Ltd, Glasgow, United Kingdom (M.D.H.).

3. Cardiology Division, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (S.L.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

2. Myocardial Remodeling in Hypertension

3. Compartmentalized cAMP signaling in cardiac ventricular myocytes

4. Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown

5. Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP